TickerFacts.

Integra Lifesciences Holdings Corp (IART): Revenue

Annual figures by period end, from SEC filings.

$1.64B
Year ended 2025-12-31
$1.65B
Trailing 12 months to 2026-06-30
+1.6%
3-year compound annual growth
+3.6%
5-year compound annual growth
2016-12-31: $992.08M2017-12-31: $1.19B2018-12-31: $1.47B2019-12-31: $1.52B2020-12-31: $1.37B2021-12-31: $1.54B2022-12-31: $1.56B2023-12-31: $1.54B2024-12-31: $1.61B2025-12-31: $1.64B$1.64B
2016-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.64B+1.5%2026-02-26, From 2025-01-01
2024-12-31$1.61B+4.5%2026-02-26, From 2024-01-01
2023-12-31$1.54B-1.0%2026-02-26, From 2023-01-01
2022-12-31$1.56B+1.0%2025-02-25, From 2022-01-01
2021-12-31$1.54B+12.4%2024-02-28, From 2021-01-01
2020-12-31$1.37B-9.6%2023-02-22, From 2020-01-01
2019-12-31$1.52B+3.1%2022-02-24, From 2019-01-01
2018-12-31$1.47B+23.9%2021-02-23, From 2018-01-01
2017-12-31$1.19B+19.8%2020-02-21, From 2017-01-01
2016-12-31$992.08Mn/a2019-02-26, From 2016-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31$1.64B+1.5%
Merit Medical Systems Inc (MMSI)2025-12-31$1.52B+11.8%
Penumbra Inc (PEN)2025-12-31$1.40B+17.5%
Teleflex Inc (TFX)2025-12-31$1.99B+17.2%
Haemonetics Corp (HAE)2026-03-28$1.33B-2.0%
ICU Medical Inc (ICUI)2025-12-31$2.23B-6.3%
Embecta Corp. (EMBC)2025-09-30$1.08B-3.8%
Tandem Diabetes Care Inc (TNDM)2025-12-31$1.01B+7.9%
Insulet Corp (PODD)2025-12-31$2.71B+30.7%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗